MXCT vs NVDA · rev $38.6M vs P/E 58, rev $96.22B
MaxCyte Inc (MXCT) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
MXCT currently screens at market cap $124.3M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the MXCT and NVDA stock pages for the full models.
Not investment advice.